Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

626
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
626
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

753
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
753

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial product translocation and mortality in adults hospitalised with HIV-associated tuberculosis: a prospective observational cohort study.

Research square·2026
Same author

SAHCS Guideline for the prevention, diagnosis and management of cryptococcal disease among persons living with HIV: Update to induction treatment for cryptococcal meningitis.

Southern African journal of HIV medicine·2026
Same author

"Trace-MTB" on Sputum Xpert Ultra: New Evidence for Interpretation in High-burden Settings.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Host Serum Biomarker Signatures in Mycobacteriologically Cured Pulmonary Tuberculosis Patients with Persistent Lung Inflammation on 18F-FDG PET/CT.

Diseases (Basel, Switzerland)·2026
Same author

Treatment adherence with an oral nine-month regimen for rifampicin-resistant tuberculosis in South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Re: Estimating the Early Transmission Inhibition of New Treatment Regimens for Drug-Resistant Tuberculosis.

The Journal of infectious diseases·2026

Related Experiment Video

Updated: Mar 24, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K

A Measurement Model to Quantify Systemic Bacilli Load in Severe HIV-Associated Tuberculosis.

Bianca Sossen1, Charlotte Schutz1,2, Linda Boloko1,2

  • 1Department of Medicine, Faculty of Health Sciences, University of Cape Town, Observatory, South Africa.

Open Forum Infectious Diseases
|March 23, 2026
PubMed
Summary

Measuring pathogen load in HIV-associated tuberculosis is crucial but difficult. Latent variable modeling using urine and blood tests offers a better way to estimate mycobacterial load, correlating more strongly with inflammation and mortality.

Keywords:
biomarkerdisseminationlatent class analysispathogen loadtuberculosis

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.2K
A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux

Published on: September 14, 2011

14.3K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.2K
A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux

Published on: September 14, 2011

14.3K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Biostatistics

Background:

  • Pathogen load is critical for understanding infection, but current measurement methods are often inadequate.
  • Accurate quantification of mycobacterial load in HIV-associated tuberculosis is challenging.

Purpose of the Study:

  • To develop and validate a novel method for estimating mycobacterial load in HIV-associated tuberculosis using latent variable modeling.
  • To assess the correlation of this novel pathogen load estimation with host inflammation and mortality.

Main Methods:

  • Latent variable modeling was applied to data from 519 inpatients with HIV-associated tuberculosis.
  • Urine and blood tests, rather than sputum, were utilized to capture mycobacterial load.
  • Measurement models were used to summarize covariance between different diagnostic tests.

Main Results:

  • Substantial covariance was observed between urine and blood tests for mycobacterial detection.
  • The estimated pathogen loads derived from latent variable modeling showed a stronger correlation with host inflammation markers.
  • Estimated pathogen loads were also more strongly correlated with patient mortality compared to traditional measures like blood culture time to positivity.

Conclusions:

  • Latent variable modeling provides a more robust estimation of mycobacterial load in HIV-associated tuberculosis.
  • Urine and blood tests can serve as valuable, non-sputum-based indicators for pathogen load assessment.
  • This improved pathogen load estimation has significant implications for understanding disease pathobiology and predicting patient outcomes.